23 Rare And Genetic Diseases companies

Mirae Asset believes in changing the future through investment.

The Cystic Fibrosis Foundation is a leading healthcare nonprofit organization like no other. For decades, we have been taking major steps and pioneering new way…

Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.

Investing in the future of medicine.

Equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.

Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives.

Sanofi Ventures invests in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system.

Investing in women’s health innovations.

Pfizer Ventures invests in areas of current or future strategic interest to Pfizer with the goal of remaining at the forefront of life science advances. We iden…

We're biomedical researchers investing in a new generation of translational founders.

Adjuvant is a new type of investment firm. We finance the most promising life science technologies for high-burden public health challenges.

Forbion is a leading venture capital firm that works closely with entrepreneurs to build life sciences companies that transform people’s lives.

Invested in breaking ‍through paralysis.

We are long-term investors in engineering biology to treat - or better, cure - human disease.

Aditum Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines.

Identifying true innovations and building ambitious companies.

A £250m specialist venture capital fund that invests in, and creates, new biotech companies to deliver high impact therapeutics for age-related dementias.

We invest in world-class companies that create better health technologies benefiting women, children and adolescents inclusively and globally.

415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation.

Pappas Capital invests exclusively in the life science sector.